Skip to content 
Student name
United States University
FNP 591
Professor Name
Submission Date
Healthcare Problem: Hypertension
Clinical practice guidelines enable healthcare practitioners to provide pertinent treatment. This paper examines the challenges of designing, implementing, and testing of hypertension CPG, which is a common disorder with high probabilities of patient outcomes and health management aspects. In this evaluation, the choice of guidelines will be made, and evidence-based medical therapy solutions will be proposed to address the health issue that a guideline addresses.
The evaluation aims at identifying the extent to which the guideline gives direction, more so in the management of patients, given the demographic factors, health reforms, and advancement of technology. Involvement of the stakeholders, application of the research information, and continuous review are quite essential in an attempt to advance the clinical practice principles in a way that is likely to improve the health of the patients, besides increasing the delivery of health services.
Healthcare Problem Identified
Morbidity and Mortality
One of the most critical global public health problems that causes high morbidity and mortality rates is high blood pressure. This is a great contributor to the risks of CVDs, including heart attack, stroke, cardiac arrest, and renal diseases. Peripheral artery disease, cognitive impairment, and visual loss are some of the complications that come with hypertension. Silent patients are also at the same risk of health complications in case hypertension remains unattended; they may become sick and disabled. Therefore, according to CVDs, high blood pressure results in higher chances of premature mortality.
Epidemiology
Hypertension is an international issue that impacts over one billion people, hence deemed to be of huge proportions. The WHO made an approximation of the burden of deaths caused by infectious diseases and effectiveness in emerging economies, where the estimation was made to be 1. Hypertension has already impacted 13 billion individuals in the global population, and it is projected that the number will increase to 1. 56 billion in 2025. The rates of hypertension in some areas of the US vary from those of other areas, though it is estimated at 46% prevalence rate. The variations in the occurrence and treatment of hypertension are due to gender, race, ancestral history, lifestyle, and other illnesses like diabetes and obesity. The main demographics, which are susceptible to the high prevalence of hypertension, are people of black color and individuals with low incomes.
Pathophysiology
Approximately 90-95 percent of the type of basic hypertension has no definite cause, and it evolves gradually. They encompass activation of the sympathetic system, renin-angiotensin-aldosterone system imbalance episodes, endothelial dysfunction, and renal malfunctions in the process of salt regulation. It is set by the kidney disease, hormonal disorders, or the side effects of drugs. Whatever the cause, hypertension strains the wall of the cardiac muscle, the walls of the arteries, and the organs, leading to structural modifications and organ damage.
Clinical Practice Guideline
The clinical practice guideline of hypertension management renders informative guidelines that help nurse practitioners in diagnosing, assessing, and managing hypertension patients. In brief, the ISH has recently introduced clinical management of hypertension in the first-degree kinship aged 18 and above (Verdecchia et al., 2020). These 2020 recommendations had substituted the 2017 ACC/AHA Guidelines and were founded on the 2018 ESC/ESH Guidelines for the treatment of hypertension. The state of simple guidelines is also emphasized in ISH Guidelines, which also focus on clarity and as simple a format as possible (Verdecchia et al., 2020).
They also discuss the issue of high blood pressure control in the developed and developing world in relation to the disparity in health care provision and availability. The ISH Guidelines also contain numerous goals of blood pressure in relation to age, the destruction of target organs, and other diseases that can be complex during implementation by doctors (Verdecchia et al., 2020). Nevertheless, the ISH Guidelines enable healthcare practitioners to manage hypertension by being attentive to a personalized approach to treatment and justice in the world.
Addressing Healthcare Problem
In regard to the use of clinical practice guidelines, the clinical practice guideline addresses hypertension effectively. It evaluates and examines lifestyle changes and medication in the diagnosis and evaluation of hypertension. The guideline is concentrated on the problem-related measures of evidence-based interventions for the patient and the variables of the person-centered treatment.
Repeat assessment is one of the guidelines that this guideline imposes as a form of evaluating the effectiveness of the therapy and or the degree to which the patients are adhering to blood pressure management and cardiovascular disease risk – reduction efforts (Stergiou et al., 2021). The other element in the guideline is shared decision-making as an instrument of increasing patient education and management of hypertension. The guideline provides a flowchart-like format to structure the healthcare professionals – especially the nurse practitioners – so that they can handle hypertension in the best way, and thus, improve the outcomes.
Strength of Evidence
The hypertension patient management guide also includes the International Society of Hypertension of 2020 recommendations to imply that it uses current data. These suggestions are formulated by experts on the current studies and discoveries. The fact that these guidelines are certain is subject to the quality of the research they are based on and the recommendations given. In clinical practice, common types of research methods are meta-analyses, randomized controlled trials, and big observational studies (Carey et al., 2021).
Having extended the period to the past five years, one could say that ISHW is well-grounded in terms of its guidelines and recommendations, which do not contradict the findings of well-constructed studies. In the need of determining the quality of evidence supporting the provided suggestion, ISH guidelines offer their grading of the strength of evidence. Thus, the recent states of the ISH and the exact recommendations that are up-to-date and applicable to the care of hypertension by care providers are provided.
Healthcare Providers and Patients
True, there is the hypertension clinical practice guideline that dominates the manner in which health care practitioners are expected to address this ailment. It includes the analysis and therapy of high blood pressure and its related problems. It is exhaustive, hence provides good evidence, which is useful in coming up with lifestyle and pharmaceutical care plans for the patients. Another point made by this guideline is the frequent evaluation of the outcomes, adherence, and adverse effects of the treatment (Flack & Adekola, 2020).
With the help of such a form of a guideline, HC specialists should be capable of managing hypertension and making excellent clinical decisions. The recommendation targets the education of the patient on issues regarding the control of hypertension and engagement in decision-making on their condition. The healthcare professionals, in this case, the nurse practitioners, are guided to offer a higher quality of hypertension management that would improve the results and reduce cardiovascular disease.
Effectiveness of Guidelines
Other aspects of patient care and conditions that directly correlate to the condition have significant impacts on the effectiveness of the clinical guideline, not only in regard to hypertension but in management in general. In order to assess the effect of the guideline on the blood pressure management in patients, it would first be critical to determine the prevalence of each of the employed strategies. This will entail checking the change in blood pressure of patients and comparing them with the guideline objectives. Therefore, the consideration of the capability of the guideline to avert cardiovascular occurrences, including heart attacks, strokes, and heart failure. The effectiveness of the guideline in enhancing the outcome of patient care can be gauged by reports of healthcare professionals of such events in patients regarding the implementation of the guideline.
There is also a need of examining the impacts of this guideline on patient care, as well as the alterations in daily practices of patients (Rossi et al., 2020). It can be measured through compliance with the medical prescriptions, questionnaires that were administered to the patients, as well as changes that were observed in the daily activities of the patient during the clinical visits. The guideline effects on patient activation and information about hypertension could be evaluated by other comparators that healthcare practitioners use.
It may be accomplished through the enhancement of the knowledge of patients, shared decision-making, and self-reported success in knowledge and hypertension management (Rossi et al., 2020). These features could empower healthcare professionals to assess the suitability of the clinical guidelines for hypertension patients and determine the areas that should be enhanced in managing the patients’ care and the outcome.
Analysis
Need for Revision
The hypertension clinical practice guideline may need a revisit concerning the prevailing healthcare requirements, demographics, and legal requirements. Regulatory healthcare rules and guidelines prescribed by authoritative organizations may be subjected to some careful considerations in order to alter them according to the healthcare setup where a need arises. The clinical practice guideline must also be verified with regard to the updates on the current evidence-based hypertension treatment algorithms (Liu, 2020). The changes in the new situations might necessitate the change of the guidelines, some of which are: Over time, with the population aging continuously, the conditions of hypertension experienced by healthcare practitioners may prove far more complicated and demand a personalized approach.
Hypertension control figures could be influenced by the advancement of technology and new methods of healthcare delivery, requiring new strategies. The health treatment that is delivered remotely, patient surveillance devices, and telehealth can result in an enhancement of patient engagement, patient control, and treatment outcomes. The guideline on the process of embracing these technologies in managing hypertension should also include these points (Liu, 2020). Current research and other information that is obtained could result in the realization of the causes of hypertension, factors that correlate with it, and how the condition may be managed. The update in the guideline should include these advances in order to arrive at the new recommended patient care of the practitioners.
Revising the Clinical Practice Guideline for Hypertension
Additional data, systematic reviews, and meta-analyses would be required to develop the new hypertension clinical practice guideline. Therefore, it involves the examination of the recent sources of literature on diet and exercise, medication, and risk-assessment instruments in the management of hypertension. The new guidelines can make sure that healthcare practitioners with the strongest evidence in making decisions related to the patients are updated. Nevertheless, the disparities in healthcare access and the definition of patient populations change should be taken into account when modifying the guideline. It presupposes the evaluation of the epidemiology of hypertension, risk factors, and therapeutic outcomes under the following demographics: age, race, ethnicity, socioeconomic status, and geographical area (Mitsuhide Naruse et al., 2022).
It could empower all patients as it is non-accepting of the new guideline that is in reference to the implementation of evidence-based approaches to eliminate disparities and foster health equality. Agency declaration should also incorporate digital health technologies and technologies in the hypertension management. This means considering greater patient engagement and self-management that was encouraged by telehealth, remote monitoring devices, smartphone apps, and wearables. Theoretically, the new guideline can enable the use of technology in the optimization of the performance of healthcare professionals concerning the patients they serve by expanding the adoption of evidence-based guidelines.
Impact of Demographics and Healthcare Reform
The clinical practice involving hypertension may be affected by several factors, such as demography of the US citizens and the healthcare reform. Since the citizens will start ageing and becoming more diverse, healthcare professionals will observe increased rates of hypertension and customers under individual treatment (Mitsuhide Naruse et al., 2022). Screening and treatment of hypertension could also increase due to the increase in healthcare reform, to access more preventive care. Such modifications can raise awareness and patient requirements to follow the suggested approach of guideline treatment and patient-centered hypertension treatment. According to them, the healthcare reform can lead to the emergence of team-based medical practices and telemedicine therapies, which will indirectly be reflected in the guidelines.
Strategies for Successful Implementation of Clinical Practice Guidelines
A number of strategies can be used to enhance the likelihood of the clinical practice adopting and utilizing a new or revised clinical practice guideline. The key stakeholders in the development and delivery of the guidelines should be the healthcare providers, the association of professionals, policymakers, and the patient organization. Engaging stakeholders in the initial stages can bring in their input and knowledge in the guidelines; hence, increasing the level of commitment by stakeholders. The simplicity of information that adequately responds to practical queries of the HCPs and patients is of utmost importance. This implies providing easy assistance on tools and lessons to be used by practicing clinicians on their patients.
Some of the ways through which healthcare practitioners can find themselves in the position of trusting the guideline include: they can be taught about what is inside the guideline and the direction that it follows (Mitsuhide Naruse et al., 2022). The guideline can be presented and integrated in real-life seminars, internet seminars, and continuing education. It can be integrated with the electronic health record systems and Clinical Decisions technologies to support the purpose of aligning its implementation in functioning health care systems and improving the care of the patients.
Continuous checking and feedback would be the auditing compliance with the guidelines on what should be paid more attention to and how it can be further developed. This client feedback and numerous interim measures of compliance with the guideline and patient outcomes could improve the therapeutic value and usage of the guideline.
Evaluation
There are various stages involved in the assessment of the efficacy of the modified clinical practice guideline in the management of the health issue in the case of the patient. The fact that the dosing and objectives used align with the objectives of the guideline is important first. They include hypertension and blood pressure, cardiac and cardiovascular events, and medication adherence. To collect and track the data, some measures are to be undertaken. This entails the accumulation of patient data in the form of blood pressure, the medication the patient is taking, and the corresponding clinical outcomes at different times. These are quality improvement strategies, and the adoption of electronic health records can assist in facilitating the data collection process and data analysis.
In that case, there is a necessity to conduct a traditional evaluation and measurement of guidelines (Baumgartner and De Backer, 2020). This can involve review of charts, analysis of documentation, and measurement of Con constructs during the clinical interactions of the providers and the patients. The process of questioning healthcare practitioners and patients regarding the application of this guideline will most probably reveal its efficacy. Statistics is involved in reviewing and assessing the outcomes and identifying the areas of improvement. The healthcare providers can use the pre- and post-treatment results of the guideline to assess its impact on the care and outcomes of the patient.
Conclusion
An evaluation of these papers defines the importance of hypertension treatment clinical practice guidelines in the care of patients and the provision of health services. Healthcare professionals can use evidence-based recommendations to improve the outcomes of patients by identifying, assessing, and applying guidelines. We emphasize the necessity to update recommendations to consider the changing demographics, healthcare requirements, policies, and technologies. Clinical practice guidelines in treating hypertension and health equity can possibly be changed with the assistance of stakeholders, new research, and effective implementation strategies.
In order to be sure that the guidelines on the management of hypertension and other prevalent health diseases are current, accessible, and efficient, collaboration, assessment, and innovation will be required. Through evidence-based practice and promotion of continuous improvement, healthcare professionals can deliver high-quality and patient-centered care that can promote health in the community.
References
Baumgartner, H., & De Backer, J. (2020). European Heart Journal, 3(2). https://doi.org/10.1093/eurheartj/ehaa701
Carey, R. M., Wright, J. T., Taler, S. J., & Whelton, P. K. (2021). Guideline-driven management of hypertension. Circulation Research, 128(7), 827–846. https://doi.org/10.1161/circresaha.121.318083
Flack, J. M., & Adekola, B. (2020). Trends in Cardiovascular Medicine, 30(3), 160–164. https://doi.org/10.1016/j.tcm.2019.05.003
Liu, J. (2020). Highlights of the 2018 Chinese hypertension guidelines. Clinical Hypertension, 26(1). https://doi.org/10.1186/s40885-020-00141-3
Journal of Hypertension, 39(7), 1293–1302. https://doi.org/10.1097/hjh.0000000000002843
The 2020 international society of hypertension global hypertension practice guidelines – key messages and clinical considerations. European Journal of Internal Medicine, 2(3). https://doi.org/10.1016/j.ejim.2020.09.001
